134 related articles for article (PubMed ID: 29172917)
1. Prospective evaluation of a protocol for transitioning porcine lente insulin-treated diabetic cats to human recombinant protamine zinc insulin.
Gostelow R; Hazuchova K; Scudder C; Forcada Y; Church D; Niessen SJ
J Feline Med Surg; 2018 Feb; 20(2):114-121. PubMed ID: 29172917
[TBL] [Abstract][Full Text] [Related]
2. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
Nelson RW; Henley K; Cole C;
J Vet Intern Med; 2009; 23(4):787-93. PubMed ID: 19566845
[TBL] [Abstract][Full Text] [Related]
3. Comparison of lente insulin and NPH insulin therapy for the treatment of newly diagnosed diabetic dogs: a randomised study.
Fracassi F; Linari G; Del Baldo F; Di Cunzolo A; D'Angelo S; Malerba E; Carotenuto G; Bonfanti U; Corradini S
Vet Rec; 2018 Sep; 183(8):262. PubMed ID: 30030413
[TBL] [Abstract][Full Text] [Related]
4. Treatment of 46 cats with porcine lente insulin--a prospective, multicentre study.
Michiels L; Reusch CE; Boari A; Petrie G; Mandigers P; Thollot IG; Rosenberg D; Mooney C; Bonfanti U; Font A; Sparkes A; Bewig K; Clercx C; Jensen AL; Horspool LJ
J Feline Med Surg; 2008 Oct; 10(5):439-51. PubMed ID: 18619886
[TBL] [Abstract][Full Text] [Related]
5. Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus.
Linari G; Fleeman L; Gilor C; Giacomelli L; Fracassi F
J Feline Med Surg; 2022 Feb; 24(2):168-176. PubMed ID: 34009061
[TBL] [Abstract][Full Text] [Related]
6. Preliminary study of protamine zinc recombinant insulin for the treatment of diabetes mellitus in cats.
Norsworthy G; Lynn R; Cole C
Vet Ther; 2009; 10(1-2):24-8. PubMed ID: 19742445
[TBL] [Abstract][Full Text] [Related]
7. Management of cats on Lente insulin: tips and traps.
Caney SM
Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):267-82. PubMed ID: 23522172
[TBL] [Abstract][Full Text] [Related]
8. Use of glargine and lente insulins in cats with diabetes mellitus.
Weaver KE; Rozanski EA; Mahony OM; Chan DL; Freeman LM
J Vet Intern Med; 2006; 20(2):234-8. PubMed ID: 16594577
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy.
Martin GJ; Rand JS
J Feline Med Surg; 2001 Mar; 3(1):23-30. PubMed ID: 11716627
[TBL] [Abstract][Full Text] [Related]
10. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
Marshall RD; Rand JS; Morton JM
J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
[TBL] [Abstract][Full Text] [Related]
11. Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.
Gostelow R; Scudder C; Keyte S; Forcada Y; Fowkes RC; Schmid HA; Church DB; Niessen SJ
J Vet Intern Med; 2017 Mar; 31(2):355-364. PubMed ID: 28145031
[TBL] [Abstract][Full Text] [Related]
12. Effect of lente insulin for treatment of diabetes mellitus in 12 cats.
Bertoy EH; Nelson RW; Feldman EC
J Am Vet Med Assoc; 1995 Jun; 206(11):1729-31. PubMed ID: 7782245
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus.
Maggiore AD; Nelson RW; Dennis J; Johnson E; Kass PH
J Vet Intern Med; 2012; 26(1):109-15. PubMed ID: 22211582
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a quality-of-life tool for cats with diabetes mellitus.
Niessen SJ; Powney S; Guitian J; Niessen AP; Pion PD; Shaw JA; Church DB
J Vet Intern Med; 2010; 24(5):1098-105. PubMed ID: 20707839
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats.
Nelson RW; Lynn RC; Wagner-Mann CC; Michels GM
J Am Vet Med Assoc; 2001 Jan; 218(1):38-42. PubMed ID: 11149712
[TBL] [Abstract][Full Text] [Related]
16. Comparisons of different measurements for monitoring diabetic cats treated with porcine insulin zinc suspension.
Martin GJ; Rand JS
Vet Rec; 2007 Jul; 161(2):52-8. PubMed ID: 17630418
[TBL] [Abstract][Full Text] [Related]
17. Field efficacy and safety of protamine zinc recombinant human insulin in 276 dogs with diabetes mellitus.
Ward CR; Christiansen K; Li J; Bryson WL; Jerrentrup KA; Kroh C
Domest Anim Endocrinol; 2021 Apr; 75():106575. PubMed ID: 33186842
[TBL] [Abstract][Full Text] [Related]
18. Acceptance of home blood glucose monitoring by owners of recently diagnosed diabetic cats and impact on quality of life changes in cat and owner.
Hazuchova K; Gostelow R; Scudder C; Forcada Y; Church DB; Niessen SJ
J Feline Med Surg; 2018 Aug; 20(8):711-720. PubMed ID: 28911254
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of protamine zinc recombinant human insulin in healthy dogs.
Clark M; Thomaseth K; Heit M; Hoenig M
J Vet Pharmacol Ther; 2012 Aug; 35(4):342-50. PubMed ID: 22758791
[TBL] [Abstract][Full Text] [Related]
20. Control of diabetes mellitus in cats with porcine insulin zinc suspension.
Martin GJ; Rand JS
Vet Rec; 2007 Jul; 161(3):88-94. PubMed ID: 17652434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
